Neogen Price to Book Ratio 2011-2025 | NEOG
Historical price to book ratio values for Neogen (NEOG) over the last 10 years. The current price to book ratio for Neogen as of November 12, 2025 is 0.67.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Neogen Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-11-12 | 6.47 | 0.66 | |
| 2025-08-31 | 5.75 | $9.75 | 0.59 |
| 2025-05-31 | 5.86 | $9.54 | 0.61 |
| 2025-02-28 | 10.05 | $12.26 | 0.82 |
| 2024-11-30 | 14.18 | $12.30 | 1.15 |
| 2024-08-31 | 17.25 | $14.47 | 1.19 |
| 2024-05-31 | 13.15 | $14.52 | 0.91 |
| 2024-02-29 | 17.19 | $14.52 | 1.18 |
| 2023-11-30 | 16.97 | $14.54 | 1.17 |
| 2023-08-31 | 23.12 | $14.54 | 1.59 |
| 2023-05-31 | 17.49 | $14.49 | 1.21 |
| 2023-02-28 | 17.69 | $14.46 | 1.22 |
| 2022-11-30 | 16.56 | $14.37 | 1.15 |
| 2022-08-31 | 20.90 | $8.20 | 2.55 |
| 2022-05-31 | 26.46 | $8.23 | 3.21 |
| 2022-02-28 | 35.70 | $8.12 | 4.40 |
| 2021-11-30 | 40.13 | $8.03 | 5.00 |
| 2021-08-31 | 43.78 | $7.96 | 5.50 |
| 2021-05-31 | 46.16 | $7.82 | 5.90 |
| 2021-02-28 | 40.96 | $7.55 | 5.43 |
| 2020-11-30 | 37.11 | $7.30 | 5.08 |
| 2020-08-31 | 38.10 | $7.08 | 5.38 |
| 2020-05-31 | 35.61 | $6.85 | 5.20 |
| 2020-02-29 | 30.38 | $6.73 | 4.52 |
| 2019-11-30 | 33.29 | $6.55 | 5.08 |
| 2019-08-31 | 35.26 | $6.30 | 5.60 |
| 2019-05-31 | 28.18 | $6.11 | 4.61 |
| 2019-02-28 | 30.98 | $5.95 | 5.21 |
| 2018-11-30 | 32.43 | $5.78 | 5.61 |
| 2018-08-31 | 46.72 | $5.59 | 8.35 |
| 2018-05-31 | 37.86 | $5.41 | 6.99 |
| 2018-02-28 | 29.14 | $5.25 | 5.55 |
| 2017-11-30 | 31.46 | $5.05 | 6.23 |
| 2017-08-31 | 25.84 | $4.78 | 5.41 |
| 2017-05-31 | 23.73 | $4.63 | 5.12 |
| 2017-02-28 | 24.32 | $4.44 | 5.47 |
| 2016-11-30 | 23.73 | $4.29 | 5.53 |
| 2016-08-31 | 22.15 | $4.15 | 5.34 |
| 2016-05-31 | 18.51 | $4.03 | 4.59 |
| 2016-02-29 | 18.47 | $3.88 | 4.76 |
| 2015-11-30 | 22.15 | $3.78 | 5.85 |
| 2015-08-31 | 19.36 | $3.67 | 5.27 |
| 2015-05-31 | 17.53 | $3.54 | 4.94 |
| 2015-02-28 | 19.18 | $3.41 | 5.63 |
| 2014-11-30 | 16.62 | $3.32 | 5.01 |
| 2014-08-31 | 15.79 | $3.24 | 4.88 |
| 2014-05-31 | 14.17 | $3.13 | 4.53 |
| 2014-02-28 | 16.24 | $2.98 | 5.45 |
| 2013-11-30 | 19.08 | $2.89 | 6.61 |
| 2013-08-31 | 13.52 | $2.79 | 4.84 |
| 2013-05-31 | 13.62 | $2.68 | 5.07 |
| 2013-02-28 | 11.70 | $2.57 | 4.56 |
| 2012-11-30 | 11.39 | $2.49 | 4.57 |
| 2012-08-31 | 9.76 | $2.41 | 4.05 |
| 2012-05-31 | 9.73 | $2.32 | 4.20 |
| 2012-02-29 | 8.67 | $2.23 | 3.89 |
| 2011-11-30 | 8.81 | $2.16 | 4.08 |
| 2011-08-31 | 8.68 | $2.10 | 4.13 |
| 2011-05-31 | 11.21 | $2.03 | 5.53 |
| 2011-02-28 | 9.35 | $1.92 | 4.86 |
| 2010-11-30 | 9.29 | $1.86 | 4.99 |
| 2010-08-31 | 7.30 | $1.77 | 4.13 |
| 2010-05-31 | 6.43 | $1.69 | 3.80 |
| 2010-02-28 | 6.06 | $1.62 | 3.73 |
| 2009-11-30 | 5.42 | $1.57 | 3.44 |
| 2009-08-31 | 4.67 | $1.51 | 3.08 |
| 2009-05-31 | 3.67 | $1.46 | 2.52 |
| 2009-02-28 | 3.54 | $1.41 | 2.51 |
| 2008-11-30 | 3.76 | $1.37 | 2.75 |
| 2008-08-31 | 4.34 | $1.33 | 3.27 |
| 2008-05-31 | 4.39 | $1.28 | 3.44 |
| 2008-02-29 | 4.50 | $1.22 | 3.69 |
| 2007-11-30 | 4.42 | $1.18 | 3.74 |
| 2007-08-31 | 3.54 | $1.13 | 3.12 |
| 2007-05-31 | 3.04 | $1.09 | 2.78 |
| 2007-02-28 | 2.54 | $1.06 | 2.40 |
| 2006-11-30 | 2.26 | $1.03 | 2.19 |
| 2006-08-31 | 2.11 | $1.00 | 2.10 |
| 2006-05-31 | 2.27 | $0.87 | 2.59 |
| 2006-02-28 | 2.52 | $0.83 | 3.05 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.419B | $0.895B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $220.837B | 25.45 |
| EssilorLuxottica (ESLOY) | France | $169.692B | 0.00 |
| Boston Scientific (BSX) | United States | $151.950B | 34.75 |
| Stryker (SYK) | United States | $139.087B | 27.62 |
| Medtronic (MDT) | Ireland | $122.368B | 17.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.739B | 0.00 |
| Agilent Technologies (A) | United States | $42.361B | 27.42 |
| ResMed (RMD) | United States | $36.840B | 25.50 |
| GE HealthCare Technologies (GEHC) | United States | $33.440B | 15.99 |
| Koninklijke Philips (PHG) | Netherlands | $28.242B | 18.45 |
| Terumo (TRUMY) | Japan | $24.252B | 28.74 |
| Insulet (PODD) | United States | $22.953B | 71.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.539B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.204B | 0.00 |
| Baxter (BAX) | United States | $9.382B | 7.57 |
| Sunny Optical Technology (SNPTF) | China | $9.339B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.452B | 30.39 |
| Demant (WILYY) | Denmark | $7.496B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.539B | 10.78 |
| ICU Medical (ICUI) | United States | $3.536B | 22.45 |
| Haemonetics (HAE) | United States | $3.358B | 14.94 |
| Envista Holdings (NVST) | United States | $3.323B | 19.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.913B | 13.28 |
| LeMaitre Vascular (LMAT) | United States | $2.050B | 41.26 |
| Perrigo (PRGO) | Ireland | $1.968B | 4.93 |
| Curaleaf Holdings (CURLF) | Canada | $1.896B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.837B | 18.35 |
| AtriCure (ATRC) | United States | $1.634B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.504B | 65.91 |
| QuidelOrtho (QDEL) | United States | $1.487B | 9.56 |
| Tilray Brands (TLRY) | Canada | $1.448B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.418B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.291B | 18.71 |
| BioLife Solutions (BLFS) | United States | $1.254B | 372.00 |
| InMode (INMD) | Israel | $0.917B | 10.36 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.830B | 0.00 |
| Valneva SE (VALN) | France | $0.764B | 0.00 |
| Surmodics (SRDX) | United States | $0.585B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.517B | 17.80 |
| SNDL (SNDL) | Canada | $0.486B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.481B | 0.00 |
| Omeros (OMER) | United States | $0.469B | 0.00 |
| CeriBell (CBLL) | United States | $0.464B | 0.00 |
| Evolus (EOLS) | United States | $0.453B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.431B | 0.00 |
| Cerus (CERS) | United States | $0.317B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.303B | 0.00 |
| Brainsway (BWAY) | Israel | $0.288B | 50.60 |
| Canopy Growth (CGC) | Canada | $0.288B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.283B | 0.00 |
| High Tide (HITI) | Canada | $0.261B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 151.67 |
| Sanara MedTech (SMTI) | United States | $0.250B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.241B | 19.24 |
| Quanterix (QTRX) | United States | $0.234B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.221B | 0.00 |
| Owens & Minor (OMI) | United States | $0.220B | 2.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.216B | 0.00 |
| Exagen (XGN) | United States | $0.209B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 16.16 |
| FitLife Brands (FTLF) | United States | $0.180B | 22.17 |
| OraSure Technologies (OSUR) | United States | $0.176B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| Biote (BTMD) | United States | $0.129B | 5.21 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.103B | 0.00 |
| Sharps Technology (STSS) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.099B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 13.33 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.057B | 33.00 |
| Nephros (NEPH) | United States | $0.046B | 33.31 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Zynex (ZYXI) | United States | $0.035B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.77 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |